Summary & Overview
HCPCS C1834: Implantable Intramuscular Pressure Sensor System
HCPCS Level II code C1834 designates an implantable intramuscular pressure sensor system that includes all components (for example, introducer and sensor) and explicitly excludes a mobile (wireless) software application. Nationally, this code matters as implantable physiologic monitoring devices expand across specialties such as neurology, rehabilitation, and critical care, affecting device coverage, coding clarity, and facility billing practices. Key payers in the national discussion include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will learn what C1834 represents clinically and operationally, the typical service setting for device implantation, and which major payers to consider when researching coverage. The publication provides benchmarks and payer coverage context, highlights clinical scenarios that commonly involve implantable pressure monitoring systems, and outlines policy and coding considerations relevant to hospitals, ambulatory surgical centers, and billing professionals. Data not available in the input is noted where applicable, and the focus remains on clear identification of the device, its service line, and the payer landscape for national audiences.
Billing Code Overview
HCPCS Level II code C1834 describes a pressure sensor system, includes all components (e.g., introducer, sensor), intramuscular (implantable), excludes mobile (wireless) software application. This code represents an implantable intramuscular pressure sensor system intended to measure physiologic pressure from within muscle tissue. The service type is implantable medical device and the typical site of service is inpatient or outpatient surgical setting or ambulatory surgical center where implantable device placement procedures are performed.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient with advanced heart failure and recurrent symptoms of volume overload is evaluated for long-term hemodynamic monitoring. After multidisciplinary review, an implantable intramuscular pressure sensor system is selected to measure pulmonary artery or intracardiac pressures remotely to guide medical therapy. The patient presents to an ambulatory cardiac electrophysiology or interventional cardiology lab for device implantation under conscious sedation or general anesthesia. Pre-procedure workflow includes history, medication reconciliation (anticoagulant management), informed consent, and baseline device interrogation if applicable. During the procedure, vascular access is obtained, an introducer is placed, and the implantable pressure sensor is positioned and deployed intramuscularly per manufacturer instructions. Device function is confirmed intraoperatively. The patient is observed post-procedure for hemodynamic stability and access-site complications, receives device programming and education about remote monitoring (excluding wireless mobile application billing), and is discharged with follow-up for remote pressure data review and medical management adjustments. Typical site of service is an ambulatory surgery center or hospital outpatient department specialized for cardiac device implantation.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, Separately Identifiable Evaluation and Management Service by the Same Physician on the Day of a Procedure | Use when a distinct E/M visit is performed on the same day as device implantation and documentation supports a separate evaluation. |